Parallels in invasion and angiogenesis provide pivotal points for therapeutic intervention

被引:59
作者
Eccles, SA [1 ]
机构
[1] Inst Canc Res, Canc Res UK Ctr Canc Therapeut, McElwain Labs, Sutton SM2 5NG, Surrey, England
关键词
motility; proteolysis; signalling; angiogenesis; invasion;
D O I
10.1387/ijdb.041820se
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Biological evolution is economical and successful fundamental processes are frequently recapitulated. There are remarkable similarities in the molecular mechanisms which enable tumour cells to invade into surrounding tissues and activated endothelial cells to generate new capillaries, which facilitate the growth and dissemination of cancer. Indeed these pathological processes are themselves based upon key vertebrate developmental processes, and in some cases parallel strategies used by microorganisms to colonise their hosts' tissues. The aim of this review is to explore these parallels in more detail and indicate possible pivotal points for therapeutic intervention. These novel approaches may ultimately optimise the selective targeting of processes involved in tumour invasion and angiogenesis, while sparing normal adult proliferating tissues. Strategies include inhibition of oncogenic pathways in tumour cells which not only stimulate tumour cell growth and invasion, but also initiate neoangiogenesis by upregulation of angiogenic cytokines. Secondly, downstream signalling pathways, transcriptional regulation and effectors common to both processes, and finally points of interaction/cross-talk between tumour cells and endothelial cells which are necessary to enable invasion and angiogenesis to proceed.
引用
收藏
页码:583 / 598
页数:16
相关论文
共 107 条
  • [11] HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endothelium
    Chen, JX
    Lawrence, ML
    Cunningham, G
    Christman, BW
    Meyrick, B
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2004, 96 (02) : 612 - 620
  • [12] Collisson EA, 2003, CANCER RES, V63, P5669
  • [13] The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo
    Davies, G
    Mason, MD
    Martin, TA
    Parr, C
    Watkins, G
    Lane, J
    Matsumoto, K
    Nakamura, T
    Jiang, WG
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (03) : 348 - 354
  • [14] Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer
    de Bock, CE
    Wang, Y
    [J]. MEDICINAL RESEARCH REVIEWS, 2004, 24 (01) : 13 - 39
  • [15] Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling
    Deroanne, CF
    Bonjean, K
    Servotte, S
    Devy, L
    Colige, A
    Clausse, N
    Blacher, S
    Verdin, E
    Foidart, JM
    Nusgens, BV
    Castronovo, V
    [J]. ONCOGENE, 2002, 21 (03) : 427 - 436
  • [16] Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells
    Dkhissi, F
    Lu, H
    Soria, C
    Opolon, P
    Griscelli, F
    Liu, HF
    Khattar, P
    Mishal, Z
    Perricaudet, M
    Li, H
    [J]. HUMAN GENE THERAPY, 2003, 14 (10) : 997 - 1008
  • [17] Targeting the TGFβ signaling network in human neoplasia
    Dumont, N
    Arteaga, CL
    [J]. CANCER CELL, 2003, 3 (06) : 531 - 536
  • [18] Easwaran V, 2003, CANCER RES, V63, P3145
  • [19] ECCLES S, 2003, P AM ASSOC CANC RES, V44, P2072
  • [20] ECCLES SA, 2004, J CHEMOTHER S1, V16, P123